Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 1.30
- Piotroski Score 3.00
- Grade Buy
- Symbol (IRTC)
- Company iRhythm Technologies, Inc.
- Price $82.37
- Changes Percentage (11.34%)
- Change $8.38
- Day Low $74.31
- Day High $82.50
- Year High $124.12
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/20/2025
- Fiscal Year End N/A
- Average Stock Price Target $120.00
- High Stock Price Target $190.00
- Low Stock Price Target $78.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$4.22
- Trailing P/E Ratio -22.67
- Forward P/E Ratio -22.67
- P/E Growth -22.67
- Net Income $-123,406,000
Income Statement
Quarterly
Annual
Latest News of IRTC
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
iRhythm Technologies, Inc. (IRTC) Stock Price, News, Quote & History
Morgan Stanley reports the BCI market at $400 billion, indicating a promising future for medtech. iRhythm Technologies' studies at AHA 2024 sessions highlight Zio's clinical value and economic benefit...
By Yahoo! Finance | 1 week ago -
Here's Why iRhythm Technologies (IRTC) Slid in Q3
Baron Funds' "Baron Health Care Fund" Q3 2024 letter revealed a 5.81% gain, slightly below its benchmark. IRhythm Technologies, Inc....
By Yahoo! Finance | 3 weeks ago -
iRhythm Technologies, Inc. (NASDAQ:IRTC) Just Reported Earnings, And Analysts Cut Their Target Price
iRhythm Technologies' stock dropped 16% after releasing its quarterly results, with revenues in line with predictions but smaller losses per share. Analysts expect revenue growth and reduced losses in...
By Yahoo! Finance | 3 months ago
